Curiel DT - Search Results

1

Conditionally replicative adenoviruses for ovarian cancer therapy.

Barnes MN, Coolidge CJ, Hemminki A, Alvarez RD, Curiel DT. Barnes MN, et al. Among authors: curiel dt. Mol Cancer Ther. 2002 Apr;1(6):435-9. Mol Cancer Ther. 2002. PMID: 12477056 Review.

2

Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody.

Deshane J, Cabrera G, Grim JE, Siegal GP, Pike J, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: curiel dt. Gynecol Oncol. 1995 Oct;59(1):8-14. doi: 10.1006/gyno.1995.1260. Gynecol Oncol. 1995. PMID: 7557620

3

Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme.

Feng M, Cabrera G, Deshane J, Scanlon KJ, Curiel DT. Feng M, et al. Among authors: curiel dt. Cancer Res. 1995 May 15;55(10):2024-8. Cancer Res. 1995. PMID: 7743496

4

Gene therapy approaches for inherited and acquired lung diseases.

Curiel DT, Pilewski JM, Albelda SM. Curiel DT, et al. Am J Respir Cell Mol Biol. 1996 Jan;14(1):1-18. doi: 10.1165/ajrcmb.14.1.8534480. Am J Respir Cell Mol Biol. 1996. PMID: 8534480 Review.

5

Targeted tumor killing via an intracellular antibody against erbB-2.

Deshane J, Siegal GP, Alvarez RD, Wang MH, Feng M, Cabrera G, Liu T, Kay M, Curiel DT. Deshane J, et al. Among authors: curiel dt. J Clin Invest. 1995 Dec;96(6):2980-9. doi: 10.1172/JCI118370. J Clin Invest. 1995. PMID: 8675670 Free PMC article.

6

Intracellular antibody against erbB-2 mediates targeted tumor cell eradication by apoptosis.

Deshane J, Grim J, Loechel S, Siegal GP, Alvarez RD, Curiel DT. Deshane J, et al. Among authors: curiel dt. Cancer Gene Ther. 1996 Mar-Apr;3(2):89-98. Cancer Gene Ther. 1996. PMID: 8729907

7

erbB-2 knockout employing an intracellular single-chain antibody (sFv) accomplishes specific toxicity in erbB-2-expressing lung cancer cells.

Grim J, Deshane J, Feng M, Lieber A, Kay M, Curiel DT. Grim J, et al. Among authors: curiel dt. Am J Respir Cell Mol Biol. 1996 Sep;15(3):348-54. doi: 10.1165/ajrcmb.15.3.8810638. Am J Respir Cell Mol Biol. 1996. PMID: 8810638

8

Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma.

Rosenfeld ME, Wang M, Siegal GP, Alvarez RD, Mikheeva G, Krasnykh V, Curiel DT. Rosenfeld ME, et al. Among authors: curiel dt. J Mol Med (Berl). 1996 Aug;74(8):455-62. doi: 10.1007/BF00217521. J Mol Med (Berl). 1996. PMID: 8872859

9

Gene therapy and ovarian cancer: a review.

Barnes MN, Deshane JS, Rosenfeld M, Siegal GP, Curiel DT, Alvarez RD. Barnes MN, et al. Among authors: curiel dt. Obstet Gynecol. 1997 Jan;89(1):145-55. doi: 10.1016/s0029-7844(96)00296-7. Obstet Gynecol. 1997. PMID: 8990458 Review.

10

A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow.

Kim M, Wright M, Deshane J, Accavitti MA, Tilden A, Saleh M, Vaughan WP, Carabasi MH, Rogers MD, Hockett RD Jr, Grizzle WE, Curiel DT. Kim M, et al. Among authors: curiel dt. Hum Gene Ther. 1997 Jan 20;8(2):157-70. doi: 10.1089/hum.1997.8.2-157. Hum Gene Ther. 1997. PMID: 9017419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters